Average Co-Inventor Count = 3.95
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Reata Pharmaceuticals, Inc. (14 from 61 patents)
2. Reata Pharmaceuticals Holdings, LLC (1 from 7 patents)
15 patents:
1. 12065464 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
2. 11078230 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
3. 9701709 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
4. 9556222 - A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
5. 9290536 - C4 monomethyl triterpenoid derivatives and methods of use thereof
6. 9249089 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
7. 9090574 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
8. 8993640 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
9. RE45325 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
10. RE45288 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
11. 8440820 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
12. 8394967 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
13. 8124656 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
14. 7943778 - Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
15. 7915402 - Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring